Related Experiment Video
Updated: May 16, 2026

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
[Splenic infarction. Ergotism induced by ritonavir?]
Agustín Dal Verme1, Emiliano López, Sebastián Grinspon
1Va Cátedra de Medicina, Hospital de Clínicas José de San Martín, Universidad de Buenos Aires, Buenos Aires, Argentina. agustindalverme@yahoo.com
Ergotism, a condition causing limb ischemia, can occur as a side effect of drug interactions. This case highlights the risk of ergotamine tartrate with ritonavir in HIV patients.
Area of Science:
- Pharmacology
- Clinical Medicine
- Toxicology
Background:
- Ergotism is a historical condition characterized by ischemia and gangrene, often linked to ergotamine exposure.
- Certain medications can potentiate ergotamine's effects, leading to adverse events.
- Ritonavir, an antiretroviral drug, is known to interact with various medications.
Observation:
- A 39-year-old HIV-positive male developed ergotism after taking 1 mg of ergotamine tartrate while on ritonavir treatment.
- The patient presented with classic ergotism symptoms, including ischemia and limb gangrene.
- Splenic infarction was an additional clinical manifestation observed in this case.
Findings:
- The co-administration of ergotamine tartrate and ritonavir precipitated a severe case of ergotism.
- The interaction between ritonavir and ergotamine tartrate led to significant ischemic complications, including splenic infarction.
- This case underscores the potential for serious adverse events from drug-drug interactions involving common medications.
Implications:
- Healthcare providers should be aware of the potential for ergotism when prescribing ergotamine derivatives to patients on ritonavir.
- Patients, particularly those with HIV on ritonavir therapy, should be educated about the risks of interacting medications.
- Caution is advised regarding the use of ergotamine tartrate in patients receiving ritonavir to prevent potentially life-threatening ergotism.
Related Concept Videos
Drug toxicity: Idiosyncratic Reactions
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis III: Medical Management
Dysrhythmias II: Classification of Tachyarrhythmias
Transient Ischemic Attack l: Introduction
Heart Failure Drugs: Inotropic Agents

